🇺🇸 S-adenosylmethionine in United States
105 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 105
Most-reported reactions
- Fatigue — 18 reports (17.14%)
- Nausea — 12 reports (11.43%)
- Dizziness — 11 reports (10.48%)
- Drug Ineffective — 11 reports (10.48%)
- Headache — 11 reports (10.48%)
- Somnolence — 10 reports (9.52%)
- Depression — 9 reports (8.57%)
- Pain — 9 reports (8.57%)
- Diarrhoea — 7 reports (6.67%)
- Insomnia — 7 reports (6.67%)
Other Psychiatry approved in United States
Frequently asked questions
Is S-adenosylmethionine approved in United States?
S-adenosylmethionine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for S-adenosylmethionine in United States?
US Department of Veterans Affairs is the originator. The local marketing authorisation holder may differ — check the official source linked above.